78. A patient contacts the pharmacy to report that the tablets in their refill of simvastatin 10 mg have a different color and appearance than the medication originally dispensed. Of the following, it would be most appropriate for the pharmacy technician to first:
Answer: C
The pharmacy technician should first transfer the patient's call to a pharmacist.
Transferring the patient's call to a pharmacist is the most appropriate initial action, as pharmacists are trained to assess medication-related concerns and provide expert guidance regarding the safety and efficacy of medications.
A) suggest that the patient notify their prescriber.
While notifying the prescriber is important in certain cases, it is not the first step the pharmacy technician should take. The technician is not equipped to evaluate the significance of the differences in the medication, making it more appropriate to refer the patient to a pharmacist first.
B) refer the patient to the drug manufacturer.
Referring the patient to the drug manufacturer is not advisable as the manufacturer may not provide immediate assistance regarding the patient's concerns. The pharmacist is the appropriate resource to address medication discrepancies and can provide guidance based on the patient's situation.
C) transfer the patient's call to a pharmacist.
This option is correct because a pharmacist has the expertise to address the patient's concerns about the different appearance of the medication. The pharmacist can assess whether the changes may indicate a potential issue with the medication's safety or efficacy and take appropriate action.
D) instruct the patient to return the medication to the pharmacy.
Instructing the patient to return the medication may be a necessary action later, but it should not be the first step. The technician must first gather more information and consult with a pharmacist before advising the patient on returning medications.
Conclusion
Transferring the call to a pharmacist is the best course of action as it ensures the patient receives expert evaluation of their concerns regarding medication appearance. All other options either delay necessary professional input or place the responsibility on the patient without providing immediate, informed guidance. This approach prioritizes patient safety and effective communication in pharmaceutical care.